NASDAQ:GOCO

GoHealth (GOCO) Stock Forecast, Price & News

$17.76

+0.81 (+4.78%)

(As of 05/26/2023 08:47 PM ET)

Compare

Today's Range: $16.69
▼
$18.16
50-Day Range: $7.68
▼
$19.74
52-Week Range: $4.93
▼
$20.70

Volume: 38,300 shs
Average Volume: 59,638 shs
Market Capitalization: $392.32 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $11.17

GoHealth MarketRank™ Forecast

Analyst Rating: Hold
1.50 Rating Score
Upside/Downside: 37.1% Downside
$11.17 Price Target
Short Interest: Bearish
6.33% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 1.14
Based on 4 Articles This Week
Insider Trading: Acquiring Shares
$198,110 Bought Last Quarter
Proj. Earnings Growth: Growing
From ($4.77) to ($4.19) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.45 out of 5 stars

Finance Sector

886th out of 911 stocks

Insurance Agents, Brokers, & Service Industry

20th out of 20 stocks

0.8

Analyst's Opinion

Consensus Rating
GoHealth has received a consensus rating of Hold. The company's average rating score is 1.50, and is based on no buy ratings, 1 hold rating, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of $11.17, GoHealth has a forecasted downside of 37.1% from its current price of $17.76.
Amount of Analyst Coverage
GoHealth has only been the subject of 2 research reports in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
6.33% of the float of GoHealth has been sold short.
Short Interest Ratio / Days to Cover
GoHealth has a short interest ratio ("days to cover") of 7.6.
Change versus previous month
Short interest in GoHealth has recently increased by 3.51%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
GoHealth does not currently pay a dividend.
Dividend Growth
GoHealth does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for GOCO.

4.0

News and Social Media Coverage

News Sentiment
GoHealth has a news sentiment score of 1.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.67 average news sentiment score of Finance companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for GoHealth this week, compared to 1 article on an average week.
Search Interest
2 people have searched for GOCO on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
MarketBeat Follows
6 people have added GoHealth to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, GoHealth insiders have bought more of their company's stock than they have sold. Specifically, they have bought $198,110.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
52.00% of the stock of GoHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.

1.3

Earnings and Valuation

Earnings Growth
Earnings for GoHealth are expected to grow in the coming year, from ($4.77) to ($4.19) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of GoHealth is -1.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of GoHealth is -1.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
GoHealth has a P/B Ratio of 0.75. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About GoHealth (NASDAQ:GOCO) Stock

GoHealth, Inc. operates as a health insurance marketplace and Medicare focused digital health company in the United States. It operates through four segments: MedicareInternal; MedicareExternal; Individual and Family Plans (IFP) and OtherInternal; and IFP and OtherExternal. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs. Its products include Medicare Advantage, Medicare Supplement, Medicare prescription drug plans, and Medicare Special Needs Plans; and IFP, dental plans, vision plans, and other ancillary plans to individuals. The company sells its products through carriers and online platform, as well as independent and external agencies. GoHealth, Inc. was founded in 2001 and is headquartered in Chicago, Illinois with additional offices in Charlotte, North Carolina, Lindon, Utah, Bratislava, Slovakia, and Kosice, Slovakia.

Receive GOCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GoHealth and its competitors with MarketBeat's FREE daily newsletter.

GOCO Stock News Headlines

May 27, 2023 | benzinga.com

GoHealth Stock (NASDAQ:GOCO), Insider Trading Activity

May 23, 2023 | msn.com

GoHealth forms special committee to evaluate buyout offer from investor group

May 29, 2023 | Stocks To Trade (Ad)

15 A.I. Trading Opportunities a Day

Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.

May 23, 2023 | finance.yahoo.com

GoHealth, Inc. Forms Special Committee to Begin Exploring Potential Transaction

May 20, 2023 | uk.finance.yahoo.com

Vijay Kotte Bought 1.9% More Shares In GoHealth

May 20, 2023 | americanbankingnews.com

GoHealth, Inc. (NASDAQ:GOCO) CFO Purchases $98,329.49 in Stock

May 19, 2023 | finance.yahoo.com

GoHealth Confirms Receipt of Unsolicited Acquisition Proposal From Centerbridge Partners and NVX Holdings

May 19, 2023 | seekingalpha.com

GoHealth climbs after investor group makes $20 a share takeover bid

May 29, 2023 | Stocks To Trade (Ad)

15 A.I. Trading Opportunities a Day

Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.

May 19, 2023 | americanbankingnews.com

Vijay Kotte Buys 7,241 Shares of GoHealth, Inc. (NASDAQ:GOCO) Stock

May 13, 2023 | americanbankingnews.com

GoHealth, Inc. (NASDAQ:GOCO) Forecasted to Earn Q2 2023 Earnings of ($2.66) Per Share

May 12, 2023 | markets.businessinsider.com

Bank of America Securities Sticks to Its Sell Rating for GoHealth (GOCO)

May 11, 2023 | finance.yahoo.com

GoHealth to Present at the 2023 RBC Capital Markets Global Healthcare Conference

May 10, 2023 | marketwatch.com

8-K: GoHealth, Inc.

May 10, 2023 | seekingalpha.com

GoHealth GAAP EPS of -$1.12 beats by $0.62, revenue of $183.16M misses by $1.82M

May 10, 2023 | markets.businessinsider.com

Bank of America Securities Sticks to Their Sell Rating for GoHealth (GOCO)

May 10, 2023 | finance.yahoo.com

Earnings Update: GoHealth, Inc. (NASDAQ:GOCO) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts

May 10, 2023 | finance.yahoo.com

GoHealth, Inc. (NASDAQ:GOCO) Q1 2023 Earnings Call Transcript

May 10, 2023 | americanbankingnews.com

GoHealth (NASDAQ:GOCO) Posts Earnings Results, Beats Estimates By $0.62 EPS

May 8, 2023 | finance.yahoo.com

GoHealth Reports First Quarter 2023 Results

May 1, 2023 | americanbankingnews.com

GoHealth (GOCO) Scheduled to Post Earnings on Monday

April 26, 2023 | finance.yahoo.com

GoHealth to Present at the 2023 Bank of America Healthcare Conference

April 24, 2023 | finance.yahoo.com

GoHealth to Announce First Quarter 2023 Results on May 8, 2023

April 21, 2023 | americanbankingnews.com

GoHealth, Inc. (NASDAQ:GOCO) Sees Significant Growth in Short Interest

April 7, 2023 | americanbankingnews.com

Credit Suisse Group Raises GoHealth (NASDAQ:GOCO) Price Target to $8.50

March 22, 2023 | americanbankingnews.com

Q1 2023 Earnings Forecast for GoHealth, Inc. (NASDAQ:GOCO) Issued By William Blair

March 18, 2023 | finance.yahoo.com

GoHealth, Inc. (NASDAQ:GOCO) Q4 2022 Earnings Call Transcript

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive GOCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GoHealth and its competitors with MarketBeat's FREE daily newsletter.

GOCO Company Calendar

Last Earnings: 3/16/2023
Today: 5/29/2023
Next Earnings (Estimated): 8/21/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Insurance agents, brokers, & service
Sub-Industry: N/A
Sector: Finance
Current Symbol: NASDAQ:GOCO
CUSIP: N/A
CIK: 1808220
Web: www.gohealth.com
Phone: 312-386-8200
Fax: N/A
Employees: 2,467
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $11.17
High Stock Price Forecast: $14.00
Low Stock Price Forecast: $8.50
Forecasted Upside/Downside: -37.1%
Consensus Rating: Hold
Rating Score (0-4): 1.50
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($16.8157)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-148,710,000.00
Net Margins: -26.53%
Pretax Margin: -66.41%
Return on Equity: -19.00%
Return on Assets: -6.72%

Debt

Debt-to-Equity Ratio: 1.37
Current Ratio: 1.79
Quick Ratio: 1.79

Sales & Book Value

Annual Sales: $631.67 million
Price / Sales: 0.62
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $23.68 per share
Price / Book: 0.75

Miscellaneous

Outstanding Shares: 22,090,000
Free Float: 10,605,000
Market Cap: $392.32 million
Optionable: Not Optionable
Beta: 2.12

Key Executives

Mr. Brandon M. Cruz (Age 45)
Co-Founder & Non-Exec. Co-Chairman
Comp: $1.76M

Mr. Clinton P. Jones (Age 45)
Co-Founder & Exec. Co-Chairman
Comp: $930.77k

Mr. Brian P. Farley (Age 53)
Chief Legal Officer & Corp. Sec.
Comp: $590.43k

Mr. Vijay Kumar Kotte (Age 45)
CEO & Director

Mr. Jason Schulz
Chief Financial Officer

Mr. Jay Sreedharan
Chief Technology Officer

Ms. Melissa Balsan
Chief Marketing Officer

Mr. Mark Monitello
Chief HR Officer

Mr. Shane E. Cruz (Age 43)
Chief Strategy Officer

Mr. Michael Hargis
Chief Customer Engagement Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

GOCO Stock - Frequently Asked Questions

Should I buy or sell GoHealth stock right now?: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GoHealth in the last twelve months. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" GOCO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GOCO, but not buy additional shares or sell existing shares.
View GOCO analyst ratings or view top-rated stocks.
What is GoHealth's stock price forecast for 2023?: 2 Wall Street analysts have issued 12-month price objectives for GoHealth's shares. Their GOCO share price forecasts range from $8.50 to $14.00. On average, they predict the company's stock price to reach $11.17 in the next year. This suggests that the stock has a possible downside of 37.1%.
View analysts price targets for GOCO or view top-rated stocks among Wall Street analysts.
How have GOCO shares performed in 2023?: GoHealth's stock was trading at $10.45 on January 1st, 2023. Since then, GOCO shares have increased by 70.0% and is now trading at $17.76.
View the best growth stocks for 2023 here.
When is GoHealth's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, August 21st 2023.
View our GOCO earnings forecast.
How were GoHealth's earnings last quarter?: GoHealth, Inc. (NASDAQ:GOCO) released its quarterly earnings data on Thursday, March, 16th. The company reported ($7.00) earnings per share for the quarter, missing the consensus estimate of $2.55 by $9.55. The company earned $69.38 million during the quarter, compared to the consensus estimate of $394.33 million. GoHealth had a negative net margin of 26.53% and a negative trailing twelve-month return on equity of 19.00%.
What guidance has GoHealth issued on next quarter's earnings?: GoHealth updated its FY 2023 earnings guidance on Monday, May, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $750.00 million-$850.00 million, compared to the consensus revenue estimate of $784.73 million.
What is Matthew Crummack's approval rating as GoHealth's CEO?: 25 employees have rated GoHealth Chief Executive Officer Matthew Crummack on Glassdoor.com. Matthew Crummack has an approval rating of 90% among the company's employees.
What other stocks do shareholders of GoHealth own?: Based on aggregate information from My MarketBeat watchlists, some companies that other GoHealth investors own include Tesla (TSLA), Alibaba Group (BABA), CVS Health (CVS), Moderna (MRNA), Raytheon Technologies (RTX), Walmart (WMT), Cisco Systems (CSCO), Intel (INTC) and Johnson & Johnson (JNJ).

When did GoHealth IPO?: (GOCO) raised $750 million in an initial public offering (IPO) on Wednesday, July 15th 2020. The company issued 39,500,000 shares at $18.00-$20.00 per share. Goldman Sachs, BofA Securities and Morgan Stanley acted as the underwriters for the IPO and Barclays, Credit Suisse, Evercore ISI, RBC Capital Markets, William Blair, Cantor, SunTrust Robinson Humphrey and Loop Capital Markets were co-managers.
What is GoHealth's stock symbol?: GoHealth trades on the NASDAQ under the ticker symbol "GOCO."
Who are GoHealth's major shareholders?: GoHealth's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (0.27%), Geode Capital Management LLC (0.22%), Balyasny Asset Management L.P. (0.12%), Renaissance Technologies LLC (0.09%), Grantham Mayo Van Otterloo & Co. LLC (0.06%) and HRT Financial LP (0.06%). Insiders that own company stock include Anita Pramoda, Blizzard Holdings C LP Cb, Brandon M Cruz, Cayman Gp Ltd Ccp III, Clinton P Jones, Clinton P Jones, Jason Schulz, Nvx Holdings, Inc, Shane E Cruz, Travis J Matthiesen and Vijay Kotte.
View institutional ownership trends.
How do I buy shares of GoHealth?: Shares of GOCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is GoHealth's stock price today?: One share of GOCO stock can currently be purchased for approximately $17.76.
How much money does GoHealth make?: GoHealth (NASDAQ:GOCO) has a market capitalization of $392.32 million and generates $631.67 million in revenue each year. The company earns $-148,710,000.00 in net income (profit) each year or ($16.8157) on an earnings per share basis.
How many employees does GoHealth have?: The company employs 2,467 workers across the globe.
How can I contact GoHealth?: GoHealth's mailing address is 214 WEST HURON STREET, CHICAGO IL, 60654. The official website for the company is www.gohealth.com. The company can be reached via phone at 312-386-8200 or via email at ir@gohealth.com.

This page (NASDAQ:GOCO) was last updated on 5/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial